Dual functional delivery strategy for cancer immunotherapy: an interview with Zhuoya Wan
At ACS San Diego (25—29 August 2019; CA, USA), we spoke with Zhuoya Wan (University of Pittsburg, PA, USA) to learn more about her work into Indoximod, a promising therapeutic anti-cancer agent, and approaches to improve its formulation and delivery.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>